Iop Lowering Effect And Reduction Of Antiglaucomatous Medication After Trabecular Istent Inject® W (3Rd Generation) –24 Month Results

Published 2022 - 40th Congress of the ESCRS

Reference: PO391 | Type: Free paper | DOI: 10.82333/h3g4-t194